Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Reimbursement.
Reimbursement for outpatient parenteral antibiotic therapy (OPAT), like that for all health care, is regulated by a multitude of private and public policies. Not all payers reimburse all aspects of OPAT, and with those that do, obtaining payment can be a daunting task. A key to prompt payment is the correct billing code. An overview of office-based, home-based, and hospital-based OPAT reimbursement is presented.
Health Care Group, State and Federal Associates, Alexandria, VA.
J C
JC
Tierce
D000043:Abstracting and Indexing / Q000191:economics; D000553:Ambulatory Care / Q000145:classification / Q000191:economics*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D004469:Economics, Hospital; D006291:Health Policy / Q000191:economics; D006699:Home Care Services / Q000191:economics; D006801:Humans; D007262:Infusions, Intravenous / Q000145:classification / Q000191:economics*; D007349:Insurance, Health, Reimbursement / Q000706:statistics & numerical data; D008484:Medicaid / Q000191:economics; D006278:Medicare / Q000191:economics; D009819:Office Visits / Q000191:economics; D012051:Reimbursement Mechanisms / Q000191:economics*; D014481:United States
D000900:Anti-Bacterial Agents